BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 25738875)

  • 1. PARVA promotes metastasis by modulating ILK signalling pathway in lung adenocarcinoma.
    Huang AH; Pan SH; Chang WH; Hong QS; Chen JJ; Yu SL
    PLoS One; 2015; 10(3):e0118530. PubMed ID: 25738875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay between intergrin-linked kinase and ribonuclease inhibitor affects growth and metastasis of bladder cancer through signaling ILK pathways.
    Zhuang X; Lv M; Zhong Z; Zhang L; Jiang R; Chen J
    J Exp Clin Cancer Res; 2016 Aug; 35(1):130. PubMed ID: 27576342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrin-linked kinase (ILK) regulates KRAS, IPP complex and Ras suppressor-1 (RSU1) promoting lung adenocarcinoma progression and poor survival.
    Nikou S; Arbi M; Dimitrakopoulos FD; Sirinian C; Chadla P; Pappa I; Ntaliarda G; Stathopoulos GT; Papadaki H; Zolota V; Lygerou Z; Kalofonos HP; Bravou V
    J Mol Histol; 2020 Aug; 51(4):385-400. PubMed ID: 32592097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrin-linked kinase is an essential mediator for T-cadherin-dependent signaling via Akt and GSK3beta in endothelial cells.
    Joshi MB; Ivanov D; Philippova M; Erne P; Resink TJ
    FASEB J; 2007 Oct; 21(12):3083-95. PubMed ID: 17485554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA silencing of integrin-linked kinase increases the sensitivity of the A549 lung cancer cell line to cisplatin and promotes its apoptosis.
    Zhao X; Xu Z; Wang Z; Wu Z; Gong Y; Zhou L; Xiang Y
    Mol Med Rep; 2015 Jul; 12(1):960-6. PubMed ID: 25760437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymosin β4 induces invasion and migration of human colorectal cancer cells through the ILK/AKT/β-catenin signaling pathway.
    Piao Z; Hong CS; Jung MR; Choi C; Park YK
    Biochem Biophys Res Commun; 2014 Sep; 452(3):858-64. PubMed ID: 25218472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of hyperactive integrin-linked kinase leads to increased cellular radiosensitivity.
    Cordes N
    Cancer Res; 2004 Aug; 64(16):5683-92. PubMed ID: 15313908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-(1-7) inhibits the migration and invasion of A549 human lung adenocarcinoma cells through inactivation of the PI3K/Akt and MAPK signaling pathways.
    Ni L; Feng Y; Wan H; Ma Q; Fan L; Qian Y; Li Q; Xiang Y; Gao B
    Oncol Rep; 2012 Mar; 27(3):783-90. PubMed ID: 22089256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of TGF-β signaling blockade on human A549 lung adenocarcinoma cell lines.
    Xu CC; Wu LM; Sun W; Zhang N; Chen WS; Fu XN
    Mol Med Rep; 2011; 4(5):1007-15. PubMed ID: 21725601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-parvin inhibits integrin-linked kinase signaling and is downregulated in breast cancer.
    Mongroo PS; Johnstone CN; Naruszewicz I; Leung-Hagesteijn C; Sung RK; Carnio L; Rustgi AK; Hannigan GE
    Oncogene; 2004 Nov; 23(55):8959-70. PubMed ID: 15467740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrin-linked kinase regulates melanoma angiogenesis by activating NF-κB/interleukin-6 signaling pathway.
    Wani AA; Jafarnejad SM; Zhou J; Li G
    Oncogene; 2011 Jun; 30(24):2778-88. PubMed ID: 21278793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of integrin-linked kinase correlates with malignant phenotype in non-small cell lung cancer and promotes lung cancer cell invasion and migration via regulating epithelial-mesenchymal transition (EMT)-related genes.
    Chen D; Zhang Y; Zhang X; Li J; Han B; Liu S; Wang L; Ling Y; Mao S; Wang X
    Acta Histochem; 2013 Mar; 115(2):128-36. PubMed ID: 22683084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZNF452 facilitates tumor proliferation and invasion via activating AKT-GSK3β signaling pathway and predicts poor prognosis of non-small cell lung cancer patients.
    Zhang X; Zhou H; Zhang Y; Cai L; Jiang G; Li A; Miao Y; Li Q; Qiu X; Wang E
    Oncotarget; 2017 Jun; 8(24):38863-38875. PubMed ID: 28418919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Catulin drives metastasis by activating ILK and driving an αvβ3 integrin signaling axis.
    Liang CH; Chiu SY; Hsu IL; Wu YY; Tsai YT; Ke JY; Pan SH; Hsu YC; Li KC; Yang PC; Chen YL; Hong TM
    Cancer Res; 2013 Jan; 73(1):428-38. PubMed ID: 23047866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of integrin-linked kinase (ILK) in cancer progression.
    Persad S; Dedhar S
    Cancer Metastasis Rev; 2003 Dec; 22(4):375-84. PubMed ID: 12884912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs associated with tumour migration, invasion and angiogenic properties in A549 and SK-Lu1 human lung adenocarcinoma cells.
    Ho CS; Yap SH; Phuah NH; In LL; Hasima N
    Lung Cancer; 2014 Feb; 83(2):154-62. PubMed ID: 24360396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribonuclease inhibitor up-regulation inhibits the growth and induces apoptosis in murine melanoma cells through repression of angiogenin and ILK/PI3K/AKT signaling pathway.
    Li L; Pan XY; Shu J; Jiang R; Zhou YJ; Chen JX
    Biochimie; 2014 Aug; 103():89-100. PubMed ID: 24769129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ILK mediates actin filament rearrangements and cell migration and invasion through PI3K/Akt/Rac1 signaling.
    Qian Y; Zhong X; Flynn DC; Zheng JZ; Qiao M; Wu C; Dedhar S; Shi X; Jiang BH
    Oncogene; 2005 Apr; 24(19):3154-65. PubMed ID: 15735674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycogen-Synthase Kinase3beta/beta-catenin axis promotes angiogenesis through activation of vascular endothelial growth factor signaling in endothelial cells.
    Skurk C; Maatz H; Rocnik E; Bialik A; Force T; Walsh K
    Circ Res; 2005 Feb; 96(3):308-18. PubMed ID: 15662032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Breast Cancer Cell Invasion by Ras Suppressor-1 (RSU-1) Silencing Is Reversed by Growth Differentiation Factor-15 (GDF-15).
    Gkretsi V; Louca M; Stylianou A; Minadakis G; Spyrou GM; Stylianopoulos T
    Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30621163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.